These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17719579)

  • 1. Tumor necrosis factor-alpha exerts pro-myogenic action in C2C12 myoblasts via sphingosine kinase/S1P2 signaling.
    Donati C; Nincheri P; Cencetti F; Rapizzi E; Farnararo M; Bruni P
    FEBS Lett; 2007 Sep; 581(23):4384-8. PubMed ID: 17719579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingosine kinase activity is required for myogenic differentiation of C2C12 myoblasts.
    Meacci E; Nuti F; Donati C; Cencetti F; Farnararo M; Bruni P
    J Cell Physiol; 2008 Jan; 214(1):210-20. PubMed ID: 17654519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK2 is required for efficient terminal differentiation of skeletal myoblasts.
    Li J; Johnson SE
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1425-33. PubMed ID: 16729973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Sphingosine 1-Phosphate Signalling Axis in Muscle Atrophy Induced by TNFα in C2C12 Myotubes.
    Bernacchioni C; Ghini V; Squecco R; Idrizaj E; Garella R; Puliti E; Cencetti F; Bruni P; Donati C
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells.
    Billich A; Urtz N; Reuschel R; Baumruker T
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1547-55. PubMed ID: 19162217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation.
    Donati C; Cencetti F; De Palma C; Rapizzi E; Brunelli S; Cossu G; Clementi E; Bruni P
    Cell Signal; 2009 Feb; 21(2):228-36. PubMed ID: 18983913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase activity is required for sphingosine-mediated phospholipase D activation in C2C12 myoblasts.
    Meacci E; Cencetti F; Donati C; Nuti F; Becciolini L; Bruni P
    Biochem J; 2004 Aug; 381(Pt 3):655-63. PubMed ID: 15109308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
    Schnitzer SE; Weigert A; Zhou J; Brüne B
    Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor-alpha-stimulated cell proliferation is mediated through sphingosine kinase-dependent Akt activation and cyclin D expression.
    Radeff-Huang J; Seasholtz TM; Chang JW; Smith JM; Walsh CT; Brown JH
    J Biol Chem; 2007 Jan; 282(2):863-70. PubMed ID: 17114809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of sphingosine kinase-1 in mouse sperm acrosomes.
    Matsumoto K; Banno Y; Murate T; Akao Y; Nozawa Y
    J Histochem Cytochem; 2005 Feb; 53(2):243-7. PubMed ID: 15684337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine SDF1 controls multiple steps of myogenesis through atypical PKCzeta.
    Odemis V; Boosmann K; Dieterlen MT; Engele J
    J Cell Sci; 2007 Nov; 120(Pt 22):4050-9. PubMed ID: 17971416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
    Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE activity affects myogenic differentiation via mTOR signaling.
    Mori S; Tokuyama K
    Biochem Biophys Res Commun; 2007 Nov; 363(3):597-602. PubMed ID: 17892857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong induction of the Tis11B gene in myogenic differentiation.
    Busse M; Schwarzburger M; Berger F; Hacker C; Munz B
    Eur J Cell Biol; 2008 Jan; 87(1):31-8. PubMed ID: 17889962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankyrin repeat and suppressor of cytokine signaling (SOCS) box-containing protein (ASB) 15 alters differentiation of mouse C2C12 myoblasts and phosphorylation of mitogen-activated protein kinase and Akt.
    McDaneld TG; Spurlock DM
    J Anim Sci; 2008 Nov; 86(11):2897-902. PubMed ID: 18641171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis.
    Cencetti F; Bernacchioni C; Nincheri P; Donati C; Bruni P
    Mol Biol Cell; 2010 Mar; 21(6):1111-24. PubMed ID: 20089836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate is a key regulator of proliferation and differentiation in retina photoreceptors.
    Miranda GE; Abrahan CE; Politi LE; Rotstein NP
    Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4416-28. PubMed ID: 19357361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine kinase inhibitor suppresses IL-18-induced interferon-gamma production through inhibition of p38 MAPK activation in human NK cells.
    Cheon S; Song SB; Jung M; Park Y; Bang JW; Kim TS; Park H; Kim CH; Yang YH; Bang SI; Cho D
    Biochem Biophys Res Commun; 2008 Sep; 374(1):74-8. PubMed ID: 18602364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
    Ader I; Malavaud B; Cuvillier O
    Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.